Lista kandydacka substancji stanowiących bardzo duże zagrożenie, oczekujących na pozwolenie
(opublikowane zgodnie z art. 59 ust. 10 rozporządzenia REACH)
Lista kandydacka substancji stanowiących bardzo duże zagrożenie, oczekujących na pozwolenie
Uwagi:
- Wersja autentyczna: Za autentyczną uznaje się jedynie listę kandydacką opublikowaną na tej stronie. Włączenie substancji na listę kandydacką na tej stronie może nakładać na przedsiębiorstwa bezpośrednie zobowiązania prawne, wynikające zwłaszcza z art. 7, 31 i 33 rozporządzenia REACH.
- Identyfikatory numeryczne: Każdy wpis na listę kandydacką obejmuje zarówno bezwodną, jak i uwodnioną postać substancji. Numer CAS wyświetlany we wpisie jest zwykle dla postaci bezwodnej. Postaci uwodnione substancji określone innymi numerami CAS również podlegają pod ten wpis.
- Inne identyfikatory numeryczne: Tam, gdzie to możliwe, dla wpisów z „-" w kolumnach dotyczących numeru WE i numeru CAS podano niewyczerpujący wykaz numerów WE lub CAS charakteryzujących substancje lub grupy substancji, które uznaje się za wchodzące w zakres wpisu na listę kandydacką. Informacje te można uzyskać, klikając przycisk „Details" dla wybranego wpisu.
Filter the list
Pokazuje 1 - 50 z 211 wyników.
Decyzja | Zestaw danych IUCLID | ||||||
---|---|---|---|---|---|---|---|
show/hide | - | - | 19/01/2021 | Toxic for reproduction (Article 57c) | Details | ||
205-594-7 | 143-24-8 | 19/01/2021 | Toxic for reproduction (Article 57c) | Details | |||
245-152-0 | 22673-19-4 | 25/06/2020 | Toxic for reproduction (Article 57c) | Details | |||
202-318-7 | 94-26-8 | 25/06/2020 | Endocrine disrupting properties (Article 57(f) - human health) | Details | |||
211-765-7 | 693-98-1 | 25/06/2020 | Toxic for reproduction (Article 57c) | Details | |||
214-012-0 | 1072-63-5 | 25/06/2020 | Toxic for reproduction (Article 57c) | Details | |||
- | - | 16/01/2020 | Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health) Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) | Details | |||
276-090-2 | 71850-09-4 | 16/01/2020 | Toxic for reproduction (Article 57c) | Details | |||
400-600-6 | 71868-10-5 | 16/01/2020 | Toxic for reproduction (Article 57c) | Details | |||
404-360-3 | 119313-12-1 | 16/01/2020 | Toxic for reproduction (Article 57c) | Details | |||
show/hide tris(4-nonylphenyl, branched) phosphite, tris(nonylphenyl) phosphite Nr WE: -, 247-759-6 | Nr CAS: 26523-78-4 | - | - | 16/07/2019 | Endocrine disrupting properties (Article 57(f) - environment) | Details | ||
202-679-0 | 98-54-4 | 16/07/2019 | Endocrine disrupting properties (Article 57(f) - environment) | Details | |||
203-772-9 | 110-49-6 | 16/07/2019 | Toxic for reproduction (Article 57c) | Details | |||
covering any of their individual isomers and combinations thereof show/hide potassium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)propionate Nr WE: 266-578-3 | Nr CAS: 67118-55-2 | - | - | 16/07/2019 | Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health) Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) | Details | ||
204-927-3 | 129-00-0 | 15/01/2019 | PBT (Article 57d) vPvB (Article 57e) | Details | |||
201-581-5 | 85-01-8 | 15/01/2019 | vPvB (Article 57e) | Details | |||
205-912-4 | 206-44-0 | 15/01/2019 | PBT (Article 57d) vPvB (Article 57e) | Details | |||
205-916-6 | 207-08-9 | 15/01/2019 | Carcinogenic (Article 57a) PBT (Article 57d) vPvB (Article 57e) | Details | |||
401-720-1 | 6807-17-6 | 15/01/2019 | Toxic for reproduction (Article 57c) | Details | |||
3-benzylidene camphor; 3-BC | 239-139-9 | 15087-24-8 | 15/01/2019 | Endocrine disrupting properties (Article 57(f) - environment) | Details | ||
262-967-7 | 61788-32-7 | 27/06/2018 | vPvB (Article 57e) | Details | |||
D4 | 209-136-7 | 556-67-2 | 27/06/2018 | PBT (Article 57d) vPvB (Article 57e) | Details | ||
231-100-4 | 7439-92-1 | 27/06/2018 | Toxic for reproduction (Article 57c) | Details | |||
EDA | 203-468-6 | 107-15-3 | 27/06/2018 | Respiratory sensitising properties (Article 57(f) - human health) | Details | ||
D6 | 208-762-8 | 540-97-6 | 27/06/2018 | PBT (Article 57d) vPvB (Article 57e) | Details | ||
234-541-0 | 12008-41-2 | 27/06/2018 | Toxic for reproduction (Article 57c) | Details | |||
DCHP | 201-545-9 | 84-61-7 | 27/06/2018 | Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - human health) | Details | ||
D5 | 208-764-9 | 541-02-6 | 27/06/2018 | PBT (Article 57d) vPvB (Article 57e) | Details | ||
205-883-8 | 191-24-2 | 27/06/2018 | PBT (Article 57d) vPvB (Article 57e) | Details | |||
trimellitic anhydride; TMA | 209-008-0 | 552-30-7 | 27/06/2018 | Respiratory sensitising properties (Article 57(f) - human health) | Details | ||
with ≥0.1% w/w 4-heptylphenol, branched and linear (4-HPbl) show/hide Formaldehyde, reaction products with branched and linear heptylphenol, carbon disulfide and hydrazine Nr WE: 300-298-5 | Nr CAS: 93925-00-9 Reaction product of 1,3,4-thiadiazolidine-2,5-dithione, formaldehyde and phenol, heptyl derivs. Nr WE: 939-460-0 | Nr CAS: - | - | - | 15/01/2018 | Endocrine disrupting properties (Article 57(f) - environment) | Details | ||
205-923-4 | 218-01-9 | 15/01/2018 | Carcinogenic (Article 57a) PBT (Article 57d) vPvB (Article 57e) | Details | |||
233-710-6 | 10325-94-7 | 15/01/2018 | Carcinogenic (Article 57a) Mutagenic (Article 57b) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) | Details | |||
244-168-5 | 21041-95-2 | 15/01/2018 | Carcinogenic (Article 57a) Mutagenic (Article 57b) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) | Details | |||
208-168-9 | 513-78-0 | 15/01/2018 | Carcinogenic (Article 57a) Mutagenic (Article 57b) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) | Details | |||
200-280-6 | 56-55-3 | 15/01/2018 | Carcinogenic (Article 57a) PBT (Article 57d) vPvB (Article 57e) | Details | |||
covering any of its individual anti- and syn-isomers or any combination thereof show/hide (1S,2S,5R,6R,9S,10S,13R,14R)-1,6,7,8,9,14,15,16,17,17,18,18-Dodecachloropentacyclo[12.2.1.1⁶,⁹.0²,¹³.0⁵,¹⁰]octadeca-7,15-diene Nr WE: - | Nr CAS: 135821-03-3 (1S,2S,5S,6S,9R,10R,13R,14R)-1,6,7,8,9,14,15,16,17,17,18,18-Dodecachloropentacyclo[12.2.1.1⁶,⁹.0²,¹³.0⁵,¹⁰]octadeca-7,15-diene Nr WE: - | Nr CAS: 135821-74-8 1,6,7,8,9,14,15,16,17,17,18,18-dodecachloropentacyclo[12.2.1.16,9.02,13.05,10]octadeca-7,15-diene Nr WE: 236-948-9 | Nr CAS: 13560-89-9 | - | - | 15/01/2018 | vPvB (Article 57e) | Details | ||
PFHxS show/hide tridecafluorohexanesulphonic acid, compound with 2,2'-iminodiethanol (1:1) Nr WE: 274-462-9 | Nr CAS: 70225-16-0 Sulfonium, (thiodi-4,1-phenylene)bis[diphenyl-, salt with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid (1:2) Nr WE: - | Nr CAS: 421555-73-9 Iodonium, bis[4-(1,1-dimethylpropyl)phenyl]-, salt with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic Nr WE: - | Nr CAS: 421555-74-0 Sulfonium, tris[4-(1,1-dimethylethyl)phenyl]-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1) Nr WE: - | Nr CAS: 425670-70-8 1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, zinc salt Nr WE: - | Nr CAS: 70136-72-0 1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, compd. with N,N-diethylethanamine (1:1) Nr WE: - | Nr CAS: 72033-41-1 1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, sodium salt Nr WE: - | Nr CAS: 82382-12-5 Iodonium, bis[(1,1-dimethylethyl)phenyl]-, salt with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid (1:1) (9CI) Nr WE: - | Nr CAS: 866621-50-3 Sulfonium, (4-methylphenyl)diphenyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1) Nr WE: - | Nr CAS: 910606-39-2 Sulfonium, [4-[(2-methyl-1-oxo-2-propen-1-yl)oxy]phenyl]diphenyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1) Nr WE: - | Nr CAS: 911027-68-4 1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, cesium salt (1:1) Nr WE: - | Nr CAS: 92011-17-1 Dibenzo[k,n][1,4,7,10,13]tetraoxathiacyclopentadecinium, 19-[4-(1,1-dimethylethyl)phenyl]-6,7,9,10,12,13-hexahydro-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1) Nr WE: - | Nr CAS: 928049-42-7 1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, lithium salt (1:1) Nr WE: - | Nr CAS: 55120-77-9 Ethanaminium, N-[4-[[4-(diethylamino)phenyl][4-(ethylamino)-1-naphthalenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-ethyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1) Nr WE: - | Nr CAS: 1310480-24-0 Methanaminium, N-[4-[[4-(dimethylamino)phenyl][4-(ethylamino)-1-naphthalenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1) Nr WE: - | Nr CAS: 1310480-27-3 Methanaminium, N-[4-[[4-(dimethylamino)phenyl][4-(phenylamino)-1-naphthalenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1) Nr WE: - | Nr CAS: 1310480-28-4 Beta-Cyclodextrin, compd. with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid ion(1-)(1:1) Nr WE: - | Nr CAS: 1329995-45-0 Gamma-Cyclodextrin, compd. with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid ion(1-)(1:1) Nr WE: - | Nr CAS: 1329995-69-8 Phosphonium, triphenyl(phenylmethyl)-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1) Nr WE: - | Nr CAS: 1000597-52-3 1-Butanaminium, N,N,N-tributyl-, salt with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid Nr WE: - | Nr CAS: 108427-54-9 Ethanaminium, N,N,N-triethyl-, salt with1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid (1:1) Nr WE: - | Nr CAS: 108427-55-0 1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, compd. With pyrrolidine (1:1) Nr WE: - | Nr CAS: 1187817-57-7 Sulfonium, triphenyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1) Nr WE: - | Nr CAS: 144116-10-9 Quinolinium, 1-(carboxymethyl)-4-[2-[4-[4-(2,2-diphenylethenyl)phenyl]-1,2,3,3a,4,8b-hexahydrocyclopent[b]indol-7-yl]ethenyl]-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1) Nr WE: - | Nr CAS: 1462414-59-0 Iodonium, diphenyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1) Nr WE: - | Nr CAS: 153443-35-7 Methanaminium, N,N,N-trimethyl-, salt with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid (1:1) Nr WE: - | Nr CAS: 189274-31-5 1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, compd.with 2-methyl-2-propanamine (1:1) Nr WE: - | Nr CAS: 202189-84-2 Iodonium, bis[4-(1,1-dimethylethyl)phenyl]-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1) Nr WE: - | Nr CAS: 213740-81-9 1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, yttrium(3+) salt (3:1) Nr WE: - | Nr CAS: 41242-12-0 1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, neodymium(3+) salt (3:1) Nr WE: - | Nr CAS: 41184-65-0 1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, scandium(3+) salt (3:1) Nr WE: - | Nr CAS: 350836-93-0 1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, gallium salt (9CI) Nr WE: - | Nr CAS: 341035-71-0 Sulfonium, bis(4-methylphenyl)phenyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1) Nr WE: - | Nr CAS: 341548-85-4 | - | - | 07/07/2017 | vPvB (Article 57e) | Details | ||
201-280-9 | 80-46-6 | 12/01/2017 | Endocrine disrupting properties (Article 57(f) - environment) | Details | |||
show/hide | - | - | 12/01/2017 | Toxic for reproduction (Article 57c) PBT (Article 57d) | Details | ||
substances with a linear and/or branched alkyl chain with a carbon number of 7 covalently bound predominantly in position 4 to phenol, covering also UVCB- and well-defined substances which include any of the individual isomers or a combination thereof show/hide | - | - | 12/01/2017 | Endocrine disrupting properties (Article 57(f) - environment) | Details | ||
Bisphenol A; BPA | 201-245-8 | 80-05-7 | 12/01/2017 | Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - environment) Endocrine disrupting properties (Article 57(f) - human health) | Details | ||
200-028-5 | 50-32-8 | 20/06/2016 | Carcinogenic (Article 57a) Mutagenic (Article 57b) Toxic for reproduction (Article 57c) PBT (Article 57d) vPvB (Article 57e) | Details | |||
show/hide | - | - | 17/12/2015 | Toxic for reproduction (Article 57c) PBT (Article 57d) | Details | ||
202-716-0 | 98-95-3 | 17/12/2015 | Toxic for reproduction (Article 57c) | Details | |||
253-037-1 | 36437-37-3 | 17/12/2015 | vPvB (Article 57e) | Details | |||
223-383-8 | 3864-99-1 | 17/12/2015 | vPvB (Article 57e) | Details | |||
214-317-9 | 1120-71-4 | 17/12/2015 | Carcinogenic (Article 57a) | Details | |||
covering any of the individual stereoisomers of [1] and [2] or any combination thereof show/hide Reaction mass of 5-sec-butyl-2-(2,4-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane and 5-sec-butyl-2-(4,6-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane Nr WE: 413-720-9 | Nr CAS: 117933-89-8 2-(2,4-Dimethylcyclohex-3-ene-1-yl)-5-methyl-(1-methylpropyl)-1,3-dioxane Nr WE: 601-499-3 | Nr CAS: 117933-89-8 1,3-Dioxane, 2-[(1R,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-rel- Nr WE: - | Nr CAS: 343934-04-3 1,3-Dioxane, 2-[(1R,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans- Nr WE: - | Nr CAS: 676367-09-2 1,3-Dioxane, 2-[(1R,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-rel- Nr WE: - | Nr CAS: 343934-05-4 1,3-Dioxane, 2-[(1R,2S)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis- Nr WE: - | Nr CAS: 676367-04-7 1,3-Dioxane, 2-[(1R,2S)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans- Nr WE: - | Nr CAS: 676367-08-1 1,3-Dioxane, 2-[(1S,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis- Nr WE: - | Nr CAS: 676367-03-6 1,3-Dioxane, 2-[(1S,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans- Nr WE: - | Nr CAS: 676367-07-0 1,3-Dioxane, 2-[(1S,2S)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis- Nr WE: - | Nr CAS: 676367-02-5 1,3-Dioxane, 2-[(1S,2S)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans- Nr WE: - | Nr CAS: 676367-06-9 1,3-Dioxane, 2-[(1R,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis- Nr WE: - | Nr CAS: 676367-05-8 1,3-Dioxane, 2-(2,4-dimethyl-3-cyclohexen-1-yl)-5-methyl-5-(1-methylpropyl)- Nr WE: - | Nr CAS: 186309-28-4 | - | - | 15/06/2015 | vPvB (Article 57e) | Details | ||
with ≥ 0.3% of dihexyl phthalate (EC No. 201-559-5) show/hide 1,2-Benzenedicarboxylic acid, mixed decyl and hexyl and octyl diesters Nr WE: 272-013-1 | Nr CAS: 68648-93-1 | - | - | 15/06/2015 | Toxic for reproduction (Article 57c) | Details | ||
Pokazuje 1 - 50 z 211 wyników.
Categories Display
Oznakowane jako:
(kliknij znak, aby wyszukać właściwą treść)
Route: .live1